miR-23b-3p in BM–MSC-derived EVs contribute to the dormant state of breast cancer cells by downregulating a target gene, myristoylated alanine-rich C-kinase substrate (MARCKS), which encodes a protein that promotes cell cycling a motility. Here, MARCKS is linked to breast carcinoma.